Harfst & Associates Inc. Sells 2,948 Shares of MetLife, Inc. (NYSE:MET)

Harfst & Associates Inc. reduced its position in shares of MetLife, Inc. (NYSE:METFree Report) by 36.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,081 shares of the financial services provider’s stock after selling 2,948 shares during the quarter. Harfst & Associates Inc.’s holdings in MetLife were worth $416,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. United Asset Strategies Inc. grew its stake in shares of MetLife by 1.1% during the 4th quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider’s stock valued at $895,000 after purchasing an additional 120 shares during the period. Barrett & Company Inc. grew its stake in shares of MetLife by 1.0% during the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider’s stock valued at $978,000 after purchasing an additional 121 shares during the period. Great Valley Advisor Group Inc. grew its stake in shares of MetLife by 1.3% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider’s stock valued at $781,000 after purchasing an additional 123 shares during the period. J.W. Cole Advisors Inc. grew its stake in shares of MetLife by 2.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider’s stock valued at $495,000 after purchasing an additional 126 shares during the period. Finally, First Commonwealth Financial Corp PA grew its stake in shares of MetLife by 0.8% during the 3rd quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider’s stock valued at $1,375,000 after purchasing an additional 133 shares during the period. 94.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

MET has been the subject of a number of recent research reports. TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Barclays cut their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Wells Fargo & Company boosted their price objective on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. Keefe, Bruyette & Woods cut their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research note on Wednesday, February 12th. Finally, StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and a consensus target price of $92.58.

Get Our Latest Analysis on MetLife

MetLife Stock Up 0.3 %

NYSE MET opened at $82.46 on Thursday. The stock’s 50 day moving average is $83.48 and its 200 day moving average is $81.70. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12 month low of $67.30 and a 12 month high of $89.05. The stock has a market cap of $57.10 billion, a PE ratio of 13.81, a P/E/G ratio of 0.65 and a beta of 1.07.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Research analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. MetLife’s dividend payout ratio (DPR) is 36.52%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.